Fmoc-Gly-(Dmb)Gly-OH is a protected dipeptide-like amino acid derivative in which glycine residues are linked and the N-terminus is capped with an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting group while the second glycine side is protected as a Dmb (4,4-dimethylbenzyl) ester/ether-type protecting group as indicated by the (Dmb) designation. The molecule contains an Fmoc-carbamate at the amino terminus, a free carboxylic acid (-COOH) at the C-terminus, and a stereochemical descriptor "Dmb" that reflects the protecting group identity rather than a defined amino acid stereocenter. Fmoc-Gly-(Dmb)Gly-OH is used as a building block for stepwise peptide synthesis and for preparing peptide intermediates where orthogonal protection and controlled chemoselectivity help manage deprotection and coupling at specific functional groups.
Fmoc-Gly-(Dmb)Gly-OH is an Fmoc-protected dipeptide-like amino acid derivative in which glycine is linked to a second glycine bearing an orthogonally protected side-chain amine as the Dmb (4,4-dimethyl-2,6-dimethoxybenzyl) group. The molecule contains an N-terminal Fmoc carbamate that supports base-labile deprotection for stepwise peptide assembly, while the Dmb-protected amino functionality provides an acid- or oxidative-labile handle depending on the chosen removal conditions. The presence of two glycine residues yields a flexible, low-steric scaffold with a defined stereochemical element at the Dmb-bearing center (Dmb stereochemical descriptor) that can be maintained through coupling and selective deprotection sequences. The free C-terminal carboxylic acid enables standard amide bond formation and downstream conversion into activated derivatives for peptide synthesis, biochemical labeling, or synthetic intermediate preparation.
1. Peptide Synthesis
Fmoc-Gly-(Dmb)Gly-OH is used in peptide building and fragment coupling workflows where an Fmoc-protected N-terminus and a free C-terminal carboxyl group enable reliable amide bond formation under peptide coupling conditions. The Fmoc carbamate supports iterative solid-phase or solution-phase strategies by allowing controlled N-deprotection to expose the next coupling site while the Dmb group masks the internal amine to prevent undesired side reactions. The glycine-rich backbone contributes conformational flexibility that is compatible with assembling short peptides, peptidomimetic segments, and sequence-defined linkers. The orthogonal protection pattern supports selective deprotection and functionalization steps that can be scheduled to generate specific internal amide or amine-bearing motifs in the final peptide product.
2. Protected Amino Acid Chemistry
Fmoc-Gly-(Dmb)Gly-OH serves as a protected amino acid derivative for orthogonally protected amine chemistry, combining an N-protecting Fmoc group with a Dmb-protected internal amine. The Dmb group provides a protected amine site that can be retained during early-stage coupling and then selectively removed to reveal a nucleophilic amine for subsequent acylation, sulfonylation, carbamate formation, or conjugation. The free carboxylic acid at the C-terminus supports conversion into peptide-activated intermediates or direct coupling partners for introducing the protected dipeptide unit into larger scaffolds. The stereochemical descriptor associated with the Dmb-bearing motif can be preserved through protection/deprotection cycles, enabling controlled construction of amine-functionalized peptide analogs and synthetic intermediates.
3. Bioconjugation Chemistry
Fmoc-Gly-(Dmb)Gly-OH can be applied to chemical biology and bioconjugation routes that require masked amine presentation followed by selective unmasking for attachment to biomolecular targets. The Dmb-protected amine enables temporal control over when the reactive amine is generated, which can be coordinated with labeling schedules using orthogonal deprotection logic. The glycine linkers provide spacing that may reduce steric interference during conjugation and can help maintain accessibility of the conjugation handle on the final construct. The Fmoc group can be removed to expose an N-terminus when the conjugation strategy involves peptide-like linkers, supporting downstream formation of stable amide or urea linkages to generate defined bioconjugates for analytical or mechanistic studies.
4. Peptidomimetics And Linkers
Fmoc-Gly-(Dmb)Gly-OH is suitable for peptidomimetic and linker synthesis where a protected di-glycine motif provides a chemically manageable scaffold for building amide-rich structures. The combination of Fmoc-protected N-terminus and Dmb-protected internal amine supports sequential functionalization, enabling incorporation into larger peptide analogs while controlling which nitrogen atoms participate in subsequent coupling or derivatization. The free C-terminal carboxyl group allows attachment to diverse electrophiles or activated partners, supporting generation of internal amide bonds, terminal modifications, and side-chain functionalization patterns that mimic peptide connectivity. The resulting intermediates can feed into structure-activity relationship studies by enabling systematic variation of linker length, amine availability, and protection-deprotection timing across analog libraries.
5. Process Chemistry Intermediate
Fmoc-Gly-(Dmb)Gly-OH functions as a chiral amino acid intermediate for process-oriented synthesis of protected peptide fragments and industrial fine-chemical intermediates. The orthogonal protection system, featuring base-labile Fmoc and selectively removable Dmb, supports manufacturing-compatible step sequencing in which reactive sites can be protected during coupling and then unmasked for controlled downstream transformations. The small, glycine-based structure reduces steric complexity, which can facilitate reproducible coupling behavior and simplify purification logic relative to bulkier side-chain derivatives. The compound's defined functional group set, including a protected carbamate, a protected amine, and a free carboxylic acid, enables its use as a standardized input for producing larger protected peptides, conjugation-ready fragments, and downstream building blocks used in specialty chemical production.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Myotropic activity of allatostatins in tenebrionid beetles
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.